FLG Mutations and Atopic Dermatitis

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

14 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The primary objective is to confirm the association of the Filament-Aggregating Protein loss-of-function mutations with respect to the severity of disease (its persistence) and its association with components of the atopic triad (i.e., seasonal allergy and asthma) within our Atopic Dermatitis cohort.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at johnsonbo [at] chop.edu or 215-590-2158.

Eligibility & Criteria

IRB #:
13-010266
Official Title:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
Study Phase:
Not Applicable
Eligible Age Range:
2 - 18 Years
Gender:
All
Study Categories:
Leader
Albert C. Yan

Albert C. Yan, MD, FAAP, FAAD